Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells

Breast Cancer Research

Volumn 10, Issue 1, 2008, Pages

  Journé, Fabrice ^a   Kheddoumi, Naïma ^a   Chaboteaux, Carole ^a   Duvillier, Hugues ^a   Laurent, Guy ^b   Body, Jean Jacques ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b UNIVERSITY OF MONS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; IBANDRONIC ACID; IMIDAZOLE DERIVATIVE; ZOLEDRONIC ACID;

APOPTOSIS; ARTICLE; BONE; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BONE AND BONES; BREAST NEOPLASMS; CALCIUM; CELL LINE, TUMOR; CELL PROLIFERATION; DIPHOSPHONATES; DRUG SYNERGISM; FEMALE; HUMANS; IMIDAZOLES;

EID: 44849112230     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1845     Document Type: Article

References (33)

1. Body JJ. Tumor Bone Diseases and Osteoporosis in Cancer Patients 2000, New York, NY; Marcel Dekker.
2. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995, 10:1478-1487.
3. Derenne S, Amiot M, Barille S, Collette M, Robillard N, Berthaud P, Harousseau JL, Bataille R. Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment. J Bone Miner Res 1999, 14:2048-2056. 10.1359/jbmr.1999.14.12.2048, 10620064.
4. Fromigue O, Lagneaux L, Body JJ. Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res 2000, 15:2211-2221. 10.1359/jbmr.2000.15.11.2211, 11092402.
5. Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 2000, 82:1459-1468.
6. Hiraga T, Williams PJ, Mundy GR, Yoneda T. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res 2001, 61:4418-4424.
7. Journe F, Chaboteaux C, Magne N, Duvillier H, Laurent G, Body JJ. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines. Breast Cancer Res 2006, 8:R2. 1413981, 16417650, 10.1186/bcr1363.
8. Daubine F, Le Gall C, Gasser J, Green J, Clezardin P. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. J Natl Cancer Inst 2007, 99:322-330. 10.1093/jnci/djk054, 17312309.
9. Fromigue O, Kheddoumi N, Body JJ. Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival. Br J Cancer 2003, 89:178-184. 10.1038/sj.bjc.6601009, 12838321.
10. Lamson ML, Fox JL, Huguchi WI. Calcium and 1-hydroxyethylidene-1,1-bisphosphonic acid: polynuclear complex formation in the physiological range of pH. Int J Pharm 1984, 21:143-154.
11. Masarachia P, Weinreb M, Balena R, Rodan GA. Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones. Bone 1996, 19:281-290. 10.1016/8756-3282(96)00182-2, 8873969.
12. Thompson K, Rogers MJ, Coxon FP, Crockett JC. Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Mol Pharmacol 2006, 69:1624-1632. 10.1124/mol.105.020776, 16501031.
13. Hosfield DJ, Zhang Y, Dougan DR, Broun A, Tari LW, Swanson RV, Finn J. Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis. J Biol Chem 2004, 279:8526-8529. 10.1074/jbc.C300511200, 14672944.
14. Frith JC, Monkkonen J, Blackburn GM, Russell RG, Rogers MJ. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 1997, 12:1358-1367. 10.1359/jbmr.1997.12.9.1358, 9286751.
15. Rogers MJ. From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif Tissue Int 2004, 75:451-461. 10.1007/s00223-004-0024-1, 15332174.
16. Reinholz GG, Getz B, Sanders ES, Karpeisky MY, Padyukova N, Mikhailov SN, Ingle JN, Spelsberg TC. Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue. Breast Cancer Res Treat 2002, 71:257-268. 10.1023/A:1014418017382, 12002344.
17. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991, 88:2095-2105. 295810, 1661297, 10.1172/JCI115539.
18. Yu SP, Canzoniero LM, Choi DW. Ion homeostasis and apoptosis. Curr Opin Cell Biol 2001, 13:405-411. 10.1016/S0955-0674(00)00228-3, 11454444.
19. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988, 175:266-276. 10.1016/0014-4827(88)90191-7, 3360056.
20. Body JJ. Breast cancer: bisphosphonate therapy for metastatic bone disease. Clin Cancer Res 2006, 12:6258s-6263s. 10.1158/1078-0432.CCR-06-0840, 17062710.
21. Journe F, Chaboteaux C, Dumon JC, Leclercq G, Laurent G, Body JJ. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells. Br J Cancer 2004, 91:1703-1710.
22. Coxon FP, Helfrich MH, Larijani B, Muzylak M, Dunford JE, Marshall D, McKinnon AD, Nesbitt SA, Horton MA, Seabra MC, Ebetino FH, Rogers MJ. Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem 2001, 276:48213-48222.
23. Merrell MA, Wakchoure S, Ilvesaro JM, Zinn K, Gehrs B, Lehenkari PP, Harris KW, Selander KS. Differential effects of Ca2+ on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells. Eur J Pharmacol 2007, 559:21-31. 10.1016/j.ejphar.2006.11.064, 17214981.
24. Roelofs AJ, Thompson K, Gordon S, Rogers MJ. Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 2006, 12:6222s-6230s. 10.1158/1078-0432.CCR-06-0843, 17062705.
25. Matczak-Jon E, Kurzak B, Kafarski P, Wozna A. Coordination abilities of piperyd-1-yl-methane-1,1-diphosphonic acids towards zinc(II), magnesium(II) and calcium(II): potentiometric and NMR studies. J Inorg Biochem 2006, 100:1155-1166. 10.1016/j.jinorgbio.2006.01.005, 16497378.
26. Monkkonen J, Taskinen M, Auriola SO, Urtti A. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. J Drug Target 1994, 2:299-308. 10.3109/10611869409015910, 7858955.
27. Twiss IM, Pas O, Ramp-Koopmanschap W, Den Hartigh J, Vermeij P. The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium. J Bone Miner Res 1999, 14:784-791. 10.1359/jbmr.1999.14.5.784, 10320527.
28. Frith JC, Rogers MJ. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro. J Bone Miner Res 2003, 18:204-212. 10.1359/jbmr.2003.18.2.204, 12568397.
29. Merrell M, Suarez-Cuervo C, Harris KW, Vaananen HK, Selander KS. Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition. Breast Cancer Res Treat 2003, 81:231-241. 10.1023/A:1026126430905, 14620918.
30. Matczak-Jon E, Kurzak B, Kamecka A, Kafarski P. Interactions of zinc(II), magnesium(II) and calcium(II) with aminomethane-1,1-diphosphonic acids in aqueous solutions. Polyhedron 2002, 21:321-332.
31. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, Brown EM. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 2000, 141:4357-4364. 10.1210/en.141.12.4357, 11108243.
32. Yin JJ, Mohammad KS, Kakonen SM, Harris S, Wu-Wong JR, Wessale JL, Padley RJ, Garrett IR, Chirgwin JM, Guise TA. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci USA 2003, 100:10954-10959. 196909, 12941866, 10.1073/pnas.1830978100.
33. Lacroix M, Siwek B, Marie PJ, Body JJ. Production and regulation of interleukin-11 by breast cancer cells. Cancer letters 1998, 127:29-35. 10.1016/S0304-3835(97)00542-9, 9619855.